Imagion’s breakthrough cancer device in manufacturing milestone

Australian listed medical imaging company Imagion Biosystems has moved a step closer to trialing its breakthrough cancer detection device, with the first phase of manufacture of a nanoparticle formulation completed despite the Covid-19 pandemic. Manufacture of the company’s MagSense HER2 nanoparticle formulation proceeded uninterrupted by the pandemic under good manufacturing practice (GMP) conditions. The second…

IDT to scale up cannabis manufacture

Pharmaceutical manufacturer IDT Australia is to scale up manufacture of cannabis products following news that its customer, Cann Group has secured new export deals with customers in European Union countries. Cann has won two new export contracts which will see its medicinal cannabis range sold in the United Kingdom, Germany and other EU markets. IDT…